Modified Nucleoside Triphosphates Market
完整報告名稱與涵蓋範圍
Modified Nucleoside Triphosphates Market Size, Share & Trends Analysis Report, By Product Type (N1-Methylpseudouridine Triphosphate, Pseudouridine and 5-Methylcytidine Triphosphates, Other Modified and Labelled NTPs), By Grade (Research Grade, GMP Grade), By Application (mRNA Vaccines, mRNA Therapeutics and Gene Editing, Research and Diagnostics), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The modified nucleoside triphosphates market covers chemically modified NTPs, principally N1-methylpseudouridine, pseudouridine and 5-methylcytidine triphosphates, supplied in research and GMP grades for in vitro transcription of messenger RNA and for research and diagnostic applications. Unmodified NTPs, cap analogs and enzymes are addressed in adjacent studies and excluded.
Modified nucleotides are essential to therapeutic mRNA because they suppress innate immune activation and increase protein expression, and their consumption scales directly with mRNA drug substance output. Vaccine-era demand created a concentrated supply base and premium pricing, which has since drawn new manufacturers in China, South Korea and Europe, expanded GMP capacity and driven price normalisation. Buyers now evaluate suppliers on impurity profiles, batch-to-batch consistency, animal-origin-free synthesis, regulatory documentation and dual-sourcing potential, while developers explore alternative modifications for self-amplifying and circular RNA that may shift the product mix. Intellectual property surrounding modified nucleoside use in mRNA continues to influence commercial arrangements.
North America and Europe remain the largest consumers, and Asia Pacific is expanding as both a manufacturing and a demand region. Competition involves nucleotide chemistry specialists, diversified life science suppliers and Asian fine chemical manufacturers.
The InsightAce study delivers revenue forecasts in US$ across all product type, grade, application and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Modified Nucleoside Triphosphates Market Snapshot
Chapter 4. Global Modified Nucleoside Triphosphates Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
5.2.1. N1-Methylpseudouridine Triphosphate
5.2.2. Pseudouridine and 5-Methylcytidine Triphosphates
5.2.3. Other Modified and Labelled NTPs
Chapter 6. Market Segmentation 2: By Grade Estimates & Trend Analysis
6.1. Grade & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Grade:
6.2.1. Research Grade
6.2.2. GMP Grade
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. mRNA Vaccines
7.2.2. mRNA Therapeutics and Gene Editing
7.2.3. Research and Diagnostics
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. mRNA Developers and Manufacturers
8.2.2. CDMOs
8.2.3. Academic and Research Institutes
Chapter 9. Modified Nucleoside Triphosphates Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. TriLink BioTechnologies (Maravai LifeSciences)
11.2. Hongene Biotech Corporation
11.3. Jena Bioscience GmbH
11.4. Thermo Fisher Scientific Inc.
11.5. Merck KGaA (MilliporeSigma)
11.6. New England Biolabs, Inc.
11.7. Roche CustomBiotech
11.8. Danaher Corporation (Aldevron and Cytiva)
11.9. Yeasen Biotechnology (Shanghai) Co., Ltd.
11.10. Vazyme Biotech Co., Ltd.
11.11. ST Pharm Co., Ltd.
11.12. BOC Sciences
11.13. Biosynth
11.14. APExBIO Technology LLC
11.15. Nuclera Ltd.
圖表清單 List of Tables & Figures
Table 1. Global Modified Nucleoside Triphosphates Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 1. Global Modified Nucleoside Triphosphates Market Snapshot, 2026 & 2035
Table 2. Global Modified Nucleoside Triphosphates Revenue Forecast by Grade, 2026-2035 (US$ Mn)
Figure 2. Global Modified Nucleoside Triphosphates Market Share by Grade, 2026 & 2035
Table 3. Global Modified Nucleoside Triphosphates Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Modified NTP Consumption Linked to mRNA Drug Substance Output, 2026-2035
Table 4. Global Modified Nucleoside Triphosphates Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. GMP Modified Nucleotide Supply Base Expansion and Price Normalisation
Table 5. North America Modified Nucleoside Triphosphates Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Modified Nucleoside Triphosphates Growth Opportunity Analysis
Table 6. Europe Modified Nucleoside Triphosphates Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Impurity and Documentation Requirements Shaping Supplier Qualification
Table 7. Asia Pacific Modified Nucleoside Triphosphates Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key Modified Nucleoside Triphosphates Market Participants
Table 8. Latin America and Middle East & Africa Modified Nucleoside Triphosphates Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們